LRRK2 and Parkinson disease: These measurements in CSF support our prior work showing that lower serum B12 levels predict greater declines in ambulatory capacity in the DATATOP study.1 Further study of B12 and tHcy should be performed in contemporary PD cohorts and should also explore the relationship of B12 level with markers of LRRK2 kinase activity.4, 26